Hepatitis B virus (HBV) is a hepatotropic virus, which damage to hepatocytes is not direct,
but through the immune system. HBV specific CD4+ T cells can induce HBV specific B cells …

Chronic infection with the hepatitis B virus (HBV) affects an estimated 257 million people
worldwide and can lead to liver diseases such as cirrhosis and liver cancer. Viral replication …

It was extensively recognized that central tolerance to HBV exists in HBs-transgenic (Tg)
mice, however, the immune response to HBV vaccine may be inspired in adult HBs-Tg mice …

Hepatitis B virus (HBV) infection is a major public health concern throughout the world. It can
be treated effectively through proper medication and vaccination, although it is very difficult …

Organ transplantation has provided another chance of survival for end-stage organ failure
patients. Yet, transplant rejection is still a main challenging factor. Immunosuppressive drugs …

The post-transcriptional RNA modifications impact the dynamic regulation of gene
expression in diverse biological and physiological processes. Host RNA modifications play …

Hepatitis B virus (HBV) reactivation is a clinically significant challenge in disease
management. This review explores the immunological mechanisms underlying HBV …

Hepatocellular carcinoma (HCC) is a major contributor to cancer‐related deaths worldwide.
Hepatitis B virus (HBV) infection is a major etiologic factor leading to HCC. While there have …

Abstract Background Hepatitis B virus (HBV) infection is a major public health problem. After
HBV infection, viral antigens shift the immune balance in favor of viral escape. Sulforaphane …

Natural killer T (NKT) cells are amongst the most important innate immune cells against
hepatitis B virus (HBV) infection. Moreover, previous studies have shown that HBV infection …